查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198661

套管针市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Trocars Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2022 年至 2027 年），套管针市场预计将以近 4.2% 的复合年增长率增长。

COVID-19 大流行在短期内对市场产生了重大影响。 为了遏制冠状病毒的传播，许多择期手术已被取消或推迟。 这导致行业对套管针的需求减少。 因此，在一定程度上冲击了全球套管针市场。 例如，根据 2021 年 4 月的研究“COVID-19 对胃肠道手术结果的影响”，COVID-19 大流行正在推动各种外科胃肠道疾病治疗的范式转变。 由于越来越多的SARS-CoV-2感染患者需要住院和重症监护，世界各地的各个外科部门都推迟了择期手术，为COVID-19患者预留医疗资源。 如上所述，许多腹部手术如急性阑尾炎和急性钙化性胆囊炎被推迟。 根据手术的紧迫性、COVID-19 患者的住院负担以及医疗资源的可用性，优先选择择期手术。 因此，COVID-19 对套管针市场产生了重大影响。

糖尿病、心血管疾病和肥胖等慢性病的负担在世界范围内迅速增加。 这些慢性疾病影响了很大一部分人口，导致全世界外科手术的数量不断增加。 例如，根据美国心臟协会的 Heart & Stroke Statistics 2020 Update，美国每年发生超过 356,000 例院外心臟骤停 (OHCA)，其中 90% 以上是致命性增加。 非创伤性 OHCA 的年发病率估计为 356,461 例，每天约 1,000 例。 为此，心血管手术的需求有望增加，套管针的需求也有望相应增加。 预计这将在预测期内推动市场增长。

此外，不断增长的老年人口可能会推动行业对套管针的需求，因为老年人口容易患慢性病，而且大多数外科手术都是在老年人口上进行的。 例如，根据国家生物技术信息中心 2022 年发表的一篇题为“在 COVID-19 大流行期间推迟手术的老年外科患者的心理困扰”的论文，大约 53% 的外科手术是在老年患者身上进行的65 岁及以上。正在为 此外，根据 2022 年欧盟统计局的数据，到 2021 年，超过五分之一 (20.8%) 的欧盟人口将超过 65 岁。 因此，预计老年人口的增加将推动该行业对外科手术的需求。 因此，由于上述因素，套管针市场有望在预测期内实现健康增长。

Trockers 市场趋势

泌尿外科手术有望在预测期内显着增长

由于良性前列腺增生（BPH）、肾囊肿、囊性肾病、慢性肾病和盆腔癌等泌尿外科疾病的高发，泌尿外科手术在预测期内将出现显着增长。被认为是高度可能。 根据 Onecia Benjamin 和 Sarah L. Lappin 的一篇论文，终末期肾病 (ESRD) 每年影响美国超过 500,000 人。 此外，美国国家糖尿病、消化和肾臟疾病研究所 (NIDDK) 2020 年的一份报告发现，每年在美国，71% 的终末期肾病 (ESRD) 患者需要透析治疗，其余 29%他说他需要换肾。

此外，根据2021年12月发表在《军事医学研究》杂誌上的论文《1990年至2019年203个国家和地区尿路感染、尿路结石和良性前列腺增生的流行病学趋势》，在印度，泌尿外科疾病影响许多人。 据报导，该国的尿路感染、尿路结石和良性前列腺增生症发病率最高。 因此，泌尿系统疾病的高患病率需要适当的疾病管理，包括手术。 因此，预计在研究期间对套管针的需求会增加，因为它们是必不可少的手术器械。 因此，由于上述因素，预计该行业在预测期内将出现显着增长。

预计在预测期内北美将主导套管针市场

在预测期内，北美的套管针市场可能会出现显着增长。 在北美，美国占据了相当大的市场份额，预计在预测期内仍将占据主导地位。 这可以归因于诸如癌症、泌尿系统疾病、糖尿病和心血管疾病等疾病日益流行等因素。 根据美国疾病控制与预防中心 (CDC) 提供的统计数据，2021 年 9 月更新的数据显示，到 2030 年，美国房颤预计将影响 1210 万人。 此外，肥胖正变得越来越普遍，减肥手术已被证明可有效控制肥胖。 因此，肥胖可能会导致每年进行更多的减肥手术。 例如，根据 2021 年 6 月更新的太平洋减肥统计数据，2020 年美国进行了约 297,000 例减肥手术。 这些统计数据表明，减肥手术越来越受欢迎，并将在研究期间增加对套管针的需求。

一些市场参与者致力于实施战略举措，从而为该地区的发展做出贡献。 例如，2020年12月，CONMED在美国推出了Core Entree II Trocar型号。 同时，2021 年 5 月，Fannin Ltd 推出了 Espiner Trocar 系列。 因此，由于上述因素，北美有望在预测期内主导套管针市场。

Trocker 市场的竞争对手分析

该行业的主要公司有 B. Braun Melsungen AG、CONMED Corporation、Genicon Inc、Johnson & Johnson、LaproSurge、Medtronic PLC、Molnlycke Health Care AB、Purple Surgical、Teleflex Incorporated、The Cooper Companies.Inc、Ackermann Instrumente GmbH、BNR 和 Conmed Corp.

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 对微创手术的需求不断扩大
    • 慢性病和肥胖症患病率上升
    • 腹腔镜领域技术进展
  • 市场製约因素
    • 与使用套管针相关的并发症
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品类型
    • 一次性Trocker
    • 可重复使用的套管针
  • 按芯片类型
    • 无叶摇臂
    • 光学套管针
    • 直截了当的特罗克
    • 刀锋战士
  • 通过使用
    • 普通外科
    • 妇科手术
    • 泌尿外科
    • 其他手术
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • B. Braun Melsungen AG
    • CONMED Corporation
    • Genicon Inc.
    • Johnson & Johnson
    • LaproSurge
    • Medtronic PLC
    • Molnlycke Health Care AB
    • Purple Surgical
    • Teleflex Incorporated
    • The Cooper Companies Inc.
    • Ackermann Instrumente GmbH
    • BNR Co.Ltd.
    • Conmed Corp.

第7章 市场机会今后动向

简介目录
Product Code: 67656

The trocars market is expected to register a CAGR of nearly 4.2% during the forecast period (2022-2027).

The COVID-19 pandemic had a significant impact on the market in the short term. A large number of elective surgeries were canceled or postponed to reduce the spread of the coronavirus. This leads to a decrease in demand for trocars in the industry. Thus, it has affected the global trocars market to a certain extent. For instance, according to the study "Impact of COVID-19 on the Outcomes of Gastrointestinal Surgery" published in April 2021, the COVID-19 pandemic has brought a paradigm shift in the treatment of various surgical gastrointestinal disorders. Various surgical departments around the world postponed elective surgeries to spare health resources for COVID-19 patients due to the rising number of patients requiring hospitalization and critical care for SARS-CoV-2 infections. As per the above-mentioned study, many abdominal surgeries, such as those for acute appendicitis and acute calculous cholecystitis, have been postponed. Elective procedures were prioritized based on the surgical procedure's urgency, the COVID-19 patients' hospital burden, and the availability of healthcare resources. Thus, COVID-19 has a significant impact on the trocars market.

The burden of chronic diseases such as diabetes, cardiovascular diseases, and obesity is rapidly increasing around the world. These chronic diseases are affecting a large proportion of the population and thus increasing the number of surgical procedures across the world. For instance, according to the American Heart Association's Heart & Stroke Statistics 2020 Update, there are more than 356,000 out-of-hospital cardiac arrests (OHCA) in the United States each year, with over 90% of these being fatal. The annual incidence of non-traumatic OHCA is estimated to be 356,461, or about 1,000 people each day. This is expected to increase the demand for cardiovascular surgeries and thereby rise in demand for trocars in the industry. This is expected to drive market growth over the forecast period.

Additionally, the rise in the geriatric population is likely to drive the demand for trocars in the industry as the geriatric population is more prone to chronic diseases, and most of the surgical procedures are performed on the geriatric population. For instance, according to the article published by the National Center for Biotechnology Information, titled 'Psychological distress among elderly surgical patients who had their surgery postponed during the COVID-19 pandemic' in 2022, approximately 53% of all surgical procedures are performed on patients over the age of 65. Additionally, as per Eurostat in 2022, more than one-fifth (20.8 %) of the European Union population was aged 65 and over 2021. Thus, the rise in the geriatric population is expected to drive the demand for surgical procedures in the industry. Thus, owing to the aforementioned factors, the trocars market is expected to register healthy growth over the forecast period.

Trocars Market Trends

Urological Surgery is Expected to Exhibit Significant Growth Over the Forecast Period

Urological surgery is likely to witness significant growth during the forecast period owing to a high incidence of urologic conditions such as benign prostatic hyperplasia (BPH), renal cyst, cystic kidney diseases, chronic kidney disease, pelvic cancer, etc. According to the article published in the National Institutes of Health in September 2021 by Onecia Benjamin and Sarah L. Lappin., End-stage renal disease (ESRD) affects more than 500,000 persons in the United States annually. Furthermore, according to the National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) Report in 2020, people with end-stage renal disease (ESRD) require 71% of dialysis treatment, and the remaining 29% need a kidney transplant in the United States annually.

Moreover, as per an article titled "Epidemiological Trends Of Urinary Tract Infections, Urolithiasis and Benign Prostatic Hyperplasia in 203 Countries and Territories from 1990 to 2019" published in the Journal of 'Military Medical Research' in December 2021, in India, urology diseases affected a large number of people. The country reported the highest incidences of urinary tract infections, urolithiasis, and benign prostatic hyperplasia. Therefore, the high prevalence of urological diseases will require proper disease management including surgery. As a result, the demand for trocars is expected to increase during the study period as it is an essential surgical tool. Therefore, owing to the aforementioned factors, the segment is expected to attain significant growth over the forecast period.

North America is Expected to Dominate the Trocars Market Over the Forecast Period

North America is likely to witness significant growth in the trocars market during the forecast period. Within North America, the United States holds a substantial share of the market, and it is expected to dominate over the forecast period. This can be attributed to the factors such as the increase in the prevalence of diseases such as cancer, urological diseases, diabetes, and cardiovascular diseases among others. As per the statistics provided by the Centre for Disease Control and Prevention (CDC), data updated in September 2021, in the United States, atrial fibrillation is anticipated to affect 12.1 million people by 2030. Additionally, obesity is becoming more common, and bariatric surgery has shown to be a successful way to manage it. As a result, due to obesity, there will likely be more bariatric procedures carried out annually. For instance, according to the Pacific Bariatric statistics data updated in June 2021, in 2020, around 297,000 bariatric surgeries were performed in the United States. These statistics indicate that bariatric surgeries are becoming more and more common, which will increase demand for trocars during the study period.

Several market players are engaged in implementing strategic initiatives, thereby contributing to the region's growth. For instance, In December 2020, CONMED launched Core Entree II Trocar model in the United States. On the other hand, in May 2021, Fannin Ltd launched the Espiner Trocar range. Thus, due to the factors mentioned above, North America is expected to dominate the trocars market over the forecast period.

Trocars Market Competitor Analysis

Key players operating in the industry are B. Braun Melsungen AG, CONMED Corporation, Genicon Inc., Johnson & Johnson, LaproSurge, Medtronic PLC, Molnlycke Health Care AB, Purple Surgical, Teleflex Incorporated, The Cooper Companies Inc., Ackermann Instrumente GmbH, BNR Co.Ltd., and Conmed Corp.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand for Minimally-Invasive Surgery
    • 4.2.2 Rising Prevalence of Chronic Diseases and Obesity
    • 4.2.3 Technological Advancements in the Field of Laparoscopy
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated With the Use of Trocars
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Disposable Trocars
    • 5.1.2 Reusable Trocars
  • 5.2 By Tip Type
    • 5.2.1 Bladeless Trocars
    • 5.2.2 Optical Trocars
    • 5.2.3 Blunt Trocars
    • 5.2.4 Bladed Trocars
  • 5.3 By Application
    • 5.3.1 General Surgery
    • 5.3.2 Gynaecological Surgery
    • 5.3.3 Urological Surgery
    • 5.3.4 Other Surgeries
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 CONMED Corporation
    • 6.1.3 Genicon Inc.
    • 6.1.4 Johnson & Johnson
    • 6.1.5 LaproSurge
    • 6.1.6 Medtronic PLC
    • 6.1.7 Molnlycke Health Care AB
    • 6.1.8 Purple Surgical
    • 6.1.9 Teleflex Incorporated
    • 6.1.10 The Cooper Companies Inc.
    • 6.1.11 Ackermann Instrumente GmbH
    • 6.1.12 BNR Co.Ltd.
    • 6.1.13 Conmed Corp.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS